$ONTO

Onto Innovation (ONTO) Bets $720M on X-Ray Chip Technology

Onto Innovation (ONTO) acquired a 27% stake in Rigaku Holdings for $720M, expanding its X-ray chip tech collaboration. Q2 2026 revenue rose 35.3% YoY to $343.1M, beating guidance. Backlog exceeded $1B. Q3 guidance: $380M-$400M revenue, EPS $2.18-$2.38. H1 2026 net income fell to $93.9M from $98M YoY, with margins declining.

Original reporting
Published Sep 7, 2026, 5:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 7, 2026, 5:21 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Onto Innovation (ONTO) Bets $720M on X-Ray Chip Technology — source image
Decision brief

The 30-second read

$ONTOBullishHigh
01

Why it matters

The acquisition could accelerate Onto's product roadmap but adds financial and operational risk.

02

Market read

A material M&A move in the semiconductor equipment space with potential price impact for Onto.

03

What to watch

Potential accounting impact of fair‑value reporting and integration costs could pressure margins.

Relevance 9/10Novelty 9/10Timing: today

Background

Onto Innovation reported record Q2 results and announced the Rigaku stake in the same week, indicating aggressive expansion.

Company-level read

Ticker impact

$ONTOBullishHigh confidence
Context

Onto Innovation completed a $720M purchase of a 27% stake in Rigaku Holdings, a major minority acquisition.

Expected impact

Potential short-term upside on news, with longer-term volatility as integration unfolds.

Evidence & confidence

Deal size is material for a mid‑cap and signals aggressive growth; market typically reacts positively to strategic acquisitions.

Market effects

Strengthens outlook for semiconductor equipment and advanced packaging sector.

Highlights continued investment in U.S. chip‑tool makers despite broader market volatility.

Signals confidence in demand for X‑ray process‑control tools worldwide.

Counterpoint

The minority stake may not translate into meaningful control, risking over‑paying for limited influence.

Key entities

  • Onto Innovation

    U.S. semiconductor equipment maker.

  • Rigaku Holdings

    Japanese X‑ray technology provider.

Related articles

$LUNRMed

Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more

Midday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.

$ONTOMed

ONTO INNOVATION INC. (ONTO): Completion of Acquisition or Disposition of Assets

ONTO INNOVATION INC. (ONTO) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Onto Innovation Completes Strategic Investment in Rigaku Holdings Corporation Investment deepens strategic collaboration to advance next-generation X-ray-based process control solutions for semiconductor manufacturing Wilmington, Mass ., August 10, 2026 – Onto Innova

$ONTOMed

Onto Innovation Q2 Earnings Call Highlights

Onto Innovation (NYSE:ONTO) reported Q2 operating cash flow of $62 million and cash and short-term investments of about $1.9 billion as of June 30. In May it completed a $1.5 billion 0% convertible debt offering due 2031, netting about $1.2 billion, and used part for repurchases. Q3 revenue guidance is $380-$400 million; non-GAAP EPS about $2.28 at midpoint. Advanced-node revenue expected to grow over 35% in 2026; advanced-packaging growth outlook raised to about 80% for 2026.

$ONTOHigh

ONTO INNOVATION INC. (ONTO): Results of Operations and Financial Condition

ONTO INNOVATION INC. (ONTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Onto Innovation Reports 2026 Second Quarter Results Wilmington, Mass ., August 6, 2026 – Onto Innovation Inc. (NYSE: ONTO) (“Onto Innovation,” “Onto,” or the “Company”) today announced financial results for the second quarter of 2026. Second Quarter Business and Financial Highlig

$AMATMedAI 8/10

These 5 Chip Stocks Are Riding the AI Fab Spending Wave

The article highlights AI-driven semiconductor capex and profiles five equipment/testing stocks. Applied Materials (AMAT) raised its 2026 semiconductor equipment growth forecast to over 30%. Onto Innovation (ONTO) reported Q1 revenue of $291.95M and a $240M+ HBM purchase agreement through 2027. It also cites record results for Lam Research (LRCX), KLA (KLAC), and Teradyne (TER).

$ONTOMedAI 8/10

Top 5 Stocks That Will Ride the Data Center Chip Equipment Supercycle

The article argues that AI-driven data center demand is boosting semiconductor capital equipment sales, citing strong YTD gains and results for Applied Materials, Lam Research, KLA, ASML, and Onto Innovation. It highlights Applied’s Q2 FY2026 revenue of $7.91B and raised 2026 equipment outlook to >30%, Lam’s March-quarter $5.84B revenue and $1.47 non-GAAP EPS, KLA’s $3.42B revenue and $9.40 EPS, ASML’s Q1 2026 $10.34B revenue and raised outlook to €36B–€40B, and Onto’s record Q4 2025 $266.87M re

Onto Innovation (ONTO) Bets $720M on X-Ray Chip Technology — alphai